卡尔萨辛-1 能保护抗抗胰岛素II 诱导的心脏缩
Derk Frank1, Christian Kuhn, Martin van Eickels
1Department of Internal Medicine III, University of Heidelberg, Germany.
Circulation
|November 21, 2007
概括
在心脏中过度表达calsarcin-1 (CS1) 通过抑制calcineurin信号,可以防止病态心脏缩. 这表明CS1是心脏病的潜在治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 分子心脏病学分子心脏病学
- 在Z盘蛋白质中,Z盘蛋白质
背景情况:
- 卡尔萨辛-1 (CS1) 缺乏会使心脏对氨酸信号传递和病理性缩产生敏感性.
- 之前的研究确定了CS1在心脏功能中的作用.
研究的目的:
- 为了研究calsarcin-1 (CS1) 过度表达的潜在抗高变性作用.
- 测试CS1在体外和体内抑制病态心脏缩的假设.
主要方法:
- CS1 的腺病毒基因转移到新生儿心肌细胞中.
- 产生过度表达CS1的转基因小鼠 (CS1Tg).
- 在小鼠中用Gq-激动剂 (Ang-II,内甲素-1,) 和长期Ang-II输液进行刺激.
主要成果:
- 过度表达CS1抑制了Gq-主动剂诱导的心肌细胞缩和降低了缩基因标记物 (ANF,MCIP1.4).
- 在没有刺激的情况下,CS1Tg小鼠没有表现出病态表型.
- 在CS1Tg小鼠中,Ang-II输液引起高血压,但并没有引起心脏缩,从而保持心脏功能,并抑制了高缩基因诱导.
结论:
- 体蛋白CS1可以防止Ang-II诱导的心肌细胞缩,部分原因是通过抑制氨酸的信号传递.
- 过度表达CS1代表了一种潜在的新疗法策略,以减轻病理性心脏缩.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...


